Effectiveness of CO
genitalia, female
gynecology
postoperative care
quality of life (PRO)/palliative care
Journal
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
04
11
2019
revised:
06
12
2019
accepted:
10
12
2019
pubmed:
30
3
2020
medline:
23
12
2020
entrez:
30
3
2020
Statut:
ppublish
Résumé
Many women diagnosed with gynecological cancers undergo adjuvant therapy, which may lead to transient or permanent menopause that ultimately leads to urogenital syndrome and vulvovaginal atrophy. Studies advise against the use of estrogen in women with a history of hormone-dependent cancer. One alternative is vaginal microablative fractional CO To evaluate the effectiveness of CO A retrospective study was carried out, including all patients with a history of gynecological cancers and vulvovaginal atrophy who underwent CO A total of 1213 patients underwent CO Fractional microablative CO
Sections du résumé
BACKGROUND
Many women diagnosed with gynecological cancers undergo adjuvant therapy, which may lead to transient or permanent menopause that ultimately leads to urogenital syndrome and vulvovaginal atrophy. Studies advise against the use of estrogen in women with a history of hormone-dependent cancer. One alternative is vaginal microablative fractional CO
OBJECTIVE
To evaluate the effectiveness of CO
METHODS
A retrospective study was carried out, including all patients with a history of gynecological cancers and vulvovaginal atrophy who underwent CO
RESULTS
A total of 1213 patients underwent CO
CONCLUSIONS
Fractional microablative CO
Identifiants
pubmed: 32221022
pii: ijgc-2019-001028
doi: 10.1136/ijgc-2019-001028
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
590-595Informations de copyright
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.